AICDA and Alzheimer disease: We found that 66% and 63% of SHM were identified in hotspot motives in IgH sequences from healthy controls and AD-AID patients, whereas only 42% of SHM were targeted to hotspot motives in AID-ΔE4a patients (Fig. 4d).